Provided by Tiger Trade Technology Pte. Ltd.

Tredegar

7.78
-0.1500-1.89%
Post-market: 7.780.00000.00%19:30 EDT
Volume:114.88K
Turnover:891.54K
Market Cap:271.61M
PE:8.13
High:7.92
Open:7.89
Low:7.67
Close:7.93
52wk High:10.53
52wk Low:6.25
Shares:34.91M
Float Shares:28.88M
Volume Ratio:0.62
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9572
EPS(LYR):0.9604
ROE:15.47%
ROA:6.50%
PB:1.19
PE(LYR):8.10

Loading ...

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

GlobeNewswire
·
Apr 22

TG Metals details advanced WA gold and lithium projects and data caveats

TIPRANKS
·
Apr 20

TG Metals to Release 5.7 Million Shares From Escrow in April 2026

TIPRANKS
·
Apr 17

Goldman Sachs Reaffirms Their Hold Rating on TG Therapeutics (TGTX)

TIPRANKS
·
Apr 16

American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction

GlobeNewswire
·
Apr 08

Analysts Conflicted on These Healthcare Names: TG Therapeutics (TGTX), Insmed (INSM) and Solventum Corporation (SOLV)

TIPRANKS
·
Apr 08

Tredegar FY25 net income from ongoing operations rises to $25.7 million; net sales climbs to $698.7 million

Reuters
·
Apr 08

TG Tech Announces 2025 Annual Report Highlights and Dividend Plan

TIPRANKS
·
Mar 31

TG-17 Amends Equity Line Agreement to Refine Issuance

TIPRANKS
·
Mar 30

Tredegar announces virtual annual shareholder meeting; FY2025 audit fees drop to $2.97 million

Reuters
·
Mar 26

TG Therapeutics Credit Deal And Valuation Gap Catch Investor Attention

Simply Wall St.
·
Mar 22

TG Therapeutics Files Procedural 8-K on Financial Obligation

TIPRANKS
·
Mar 21

New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

GlobeNewswire
·
Mar 16

Tredegar Q4 Adj. EPS $0.32 Up From $0.06 YoY, Sales $154.505M Up From $122.462M YoY

Benzinga Earnings
·
Mar 11

Tredegar Q4 net income from continuing operations hits USD 14.48 million as Aluminum Extrusions EBITDA from ongoing operations rises 61% to USD 15.71 million

Reuters
·
Mar 11

Tredegar Corp - Q4 2025 Net Income From Cont Ops $14.5 Mln, $0.42 per Diluted Share

THOMSON REUTERS
·
Mar 11

Tredegar Reports Fourth Quarter and Full Year 2025 Results

THOMSON REUTERS
·
Mar 11

Tredegar Corp: Continue to Look at Cost Savings Opportunities Across Co, Including Operational and Supply Chain Efficiencies, Administrative Costs

THOMSON REUTERS
·
Mar 11

TG Jones owner Modella Capital weighs latest asset sale

cityam
·
Mar 10

TG Metals issues interim financial report for half-year to 31 December 2025

TIPRANKS
·
Mar 10